ARTICLE | Company News
PharmEste, Ario Pharma deal
October 13, 2014 7:00 AM UTC
Ario acquired transient receptor potential A1 (TrpA1) antagonist assets previously owned by PharmEste. The assets include a series of small molecule TrpA1 antagonists, patents, know-how and data. Ari...